Pay in 4 interest-free payments of $7.36 Learn more
Ships within 48 hours · Estimated delivery Sep 23 - Sep 28
In the study, half the participants lost 15% of their body weight while on a compounded GLP-1
Common Side Effects Mild injection site reactions Transient water retention Mild joint stiffness Less Common Considerations Elevated IGF-1 beyond target range Glucose dysregulation in poorly selected patients Tesamorelin should be avoided in patients with active malignancy , as growth hormone can promote cellular proliferation
There are no studies or data that show that micro-dosing works
Both semaglutide and tirzepatide are GLP-1-based injectable weight loss medications, but tirzepatide is a dual GIP/GLP-1 receptor agonist, meaning it activates an additional hormonal pathway that amplifies metabolic effects
US$ 20.69
US$ 21.52
US$ 23.90
US$ 28.43
US$ 29.20
US$ 28.94
